Why is Vaishali Pharma falling/rising?

As of 15-Oct, Vaishali Pharma Ltd's stock price is currently at Rs. 10.40, reflecting a decrease of Rs. 0.35, or 3.26%. The stock has hit a new 52-week low of Rs. 10.3 today and has underperformed its sector by 3.34%. Over the past week, the stock has declined by 6.22%, and its year-to-date performance shows a significant drop of 40.54%. The company's long-term fundamentals are weak, evidenced by a staggering -145.73% CAGR growth in operating profits over the last five years and a negative EBITDA, which indicates a risky investment. Additionally, the company's ability to service its debt is poor, with an average EBIT to interest ratio of only 1.68, and its return on equity stands at a low 7.89%.
In the broader market context, while the Sensex has gained 1.11% over the past week, Vaishali Pharma's performance has sharply contrasted with this upward trend. The stock's delivery volume has also fallen significantly, down 72.77% against the five-day average, indicating a decline in investor participation. This underperformance is further highlighted by the stock's returns over various periods, where it has consistently lagged behind the benchmark, including a 58.23% drop over the past year. Overall, the combination of weak financial metrics, poor market performance, and declining investor interest contributes to the stock's downward trajectory.